| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |